Abstract
Cholesterol is an important lipid in the context of membrane protein function. The function of a number of membrane proteins, including G protein-coupled receptors (GPCRs) and ion channels, has been shown to be dependent on membrane cholesterol. However, the molecular mechanism underlying such regulation is still being explored. In some cases, specific interaction between cholesterol and the protein has been implicated. In other cases, the effect of cholesterol on the membrane properties has been attributed for the regulation of protein function. In this article, we have provided an overview of experimental approaches that are useful for determining the degree of structural stringency of cholesterol for membrane protein function. In the process, we have highlighted the role of immediate precursors in cholesterol biosynthetic pathway in the function of membrane proteins. Special emphasis has been given to the application of stereoisomers of cholesterol in deciphering the structural stringency required for regulation of membrane protein function. A comprehensive examination of these processes would help in understanding the molecular basis of cholesterol regulation of membrane proteins in subtle details.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Lee AG (2011) Lipid–protein interactions. Biochem Soc Trans 39:761–766
Burger K, Gimpl G, Fahrenholz F (2000) Regulation of receptor function by cholesterol. Cell Mol Life Sci 57:1577–1592
Pucadyil TJ, Chattopadhyay A (2006) Role of cholesterol in the function and organization of G-protein coupled receptors. Prog Lipid Res 45:295–333
Fantini J, Barrantes FJ (2009) Sphingolipid/cholesterol regulation of neurotransmitter receptor conformation and function. Biochim Biophys Acta 1788:2345–2361
Paila YD, Chattopadhyay A (2010) Membrane cholesterol in the function and organization of G-protein coupled receptors. Subcell Biochem 51:439–466
Oates J, Watts A (2011) Uncovering the intimate relationship between lipids, cholesterol and GPCR activation. Curr Opin Struct Biol 21:802–807
Jafurulla M, Chattopadhyay A (2013) Membrane lipids in the function of serotonin and adrenergic receptors. Curr Med Chem 20:47–55
Levitan I, Singh DK, Rosenhouse-Dantsker A (2014) Cholesterol binding to ion channels. Front Physiol 5:65
Chattopadhyay A (2014) GPCRs: lipid-dependent membrane receptors that act as drug targets. Adv Biol 2014:143023
Paila YD, Chattopadhyay A (2009) The function of G-protein coupled receptors and membrane cholesterol: specific or general interaction? Glycoconj J 26:711–720
Lee AG (2011) Biological membranes: the importance of molecular detail. Trends Biochem Sci 36:493–500
Paila YD, Tiwari S, Chattopadhyay A (2009) Are specific nonannular cholesterol binding sites present in G-protein coupled receptors? Biochim Biophys Acta 1788:295–302
Simmonds AC, East JM, Jones OT, Rooney EK, McWhirter J, Lee AG (1982) Annular and non-annular binding sites on the (Ca2+ + Mg2+)-ATPase. Biochim Biophys Acta 693:398–406
Jones OT, McNamee MG (1988) Annular and nonannular binding sites for cholesterol associated with the nicotinic acetylcholine receptor. Biochemistry 27:2364–2374
Pucadyil TJ, Chattopadhyay A (2004) Cholesterol modulates ligand binding and G-protein coupling to serotonin1A receptors from bovine hippocampus. Biochim Biophys Acta 1663:188–200
Saxena R, Chattopadhyay A (2012) Membrane cholesterol stabilizes the human serotonin1A receptor. Biochim Biophys Acta 1818:2936–2942
Patra SM, Chakraborty S, Shahane G, Prasanna X, Sengupta D, Maiti PK, Chattopadhyay A (2015) Differential dynamics of the serotonin1A receptor in membrane bilayers of varying cholesterol content revealed by all atom molecular dynamics simulation. Mol Membr Biol 32:127–137
Yao Z, Kobilka BK (2005) Using synthetic lipids to stabilize purified β2 adrenoceptor in detergent micelles. Anal Biochem 343:344–346
Zocher M, Zhang C, Rasmussen SGF, Kobilka BK, Müller DJ (2012) Cholesterol increases kinetic, energetic, and mechanical stability of the human β2-adrenergic receptor. Proc Natl Acad Sci U S A 109:E3463–E3472
Paila YD, Jindal E, Goswami SK, Chattopadhyay A (2011) Cholesterol depletion enhances adrenergic signaling in cardiac myocytes. Biochim Biophys Acta 1808:461–465
Harikumar KG, Puri V, Singh RD, Hanada K, Pagano RE, Miller LJ (2005) Differential effects of modification of membrane cholesterol and sphingolipids on the conformation, function, and trafficking of the G protein-coupled cholecystokinin receptor. J Biol Chem 280:2176–2185
Sjögren B, Hamblin MW, Svenningsson P (2006) Cholesterol depletion reduces serotonin binding and signaling via human 5-HT7(a) receptors. Eur J Pharmacol 552:1–10
Gimpl G, Burger K, Fahrenholz F (1997) Cholesterol as modulator of receptor function. Biochemistry 36:10959–10974
Gimpl G, Fahrenholz F (2002) Cholesterol as stabilizer of the oxytocin receptor. Biochim Biophys Acta 1564:384–392
Oddi S, Dainese E, Fezza F, Lanuti M, Barcaroli D, De Laurenzi V, Centonze D, Maccarrone M (2011) Functional characterization of putative cholesterol binding sequence (CRAC) in human type-1 cannabinoid receptor. J Neurochem 116:858–865
Criado M, Eibl H, Barrantes FJ (1982) Effects of lipids on acetylcholine receptor. Essential need of cholesterol for maintenance of agonist-induced state transitions in lipid vesicles. Biochemistry 21:3622–3629
Fong TM, McNamee MG (1986) Correlation between acetylcholine receptor function and structural properties of membranes. Biochemistry 25:830–840
Santiago J, Guzmán GR, Rojas LV, Marti R, Asmar-Rovira GA, Santana LF, McNamee M, Lasalde-Dominicci JA (2001) Probing the effects of membrane cholesterol in the Torpedo californica acetylcholine receptor and the novel lipid-exposed mutation αC418W in Xenopus oocytes. J Biol Chem 276:46523–46532
Borroni V, Baier CJ, Lang T, Bonini I, White MM, Garbus I, Barrantes FJ (2007) Cholesterol depletion activates rapid internalization of submicron-sized acetylcholine receptor domains at the cell membrane. Mol Membr Biol 24:1–15
Barrantes FJ (2007) Cholesterol effects on nicotinic acetylcholine receptor. J Neurochem 103(Supp 1):72–80
Borroni V, Barrantes FJ (2011) Cholesterol modulates the rate and mechanism of acetylcholine receptor internalization. J Biol Chem 286:17122–17132
Sooksawate T, Simmonds MA (1998) Increased membrane cholesterol reduces the potentiation of GABAA currents by neurosteroids in dissociated hippocampal neurones. Neuropharmacology 37:1103–1110
Sooksawate T, Simmonds MA (2001) Influence of membrane cholesterol on modulation of the GABAA receptor by neuroactive steroids and other potentiators. Br J Pharmacol 134:1303–1311
Sooksawate T, Simmonds MA (2001) Effects of membrane cholesterol on the sensitivity of the GABAA receptor to GABA in acutely dissociated rat hippocampal neurones. Neuropharmacology 40:178–184
Nothdurfter C, Tanasic S, Di Benedetto B, Uhr M, Wagner E-M, Gilling KE, Parsons CG, Rein T, Holsboer F, Rupprecht R, Rammes G (2013) Lipid raft integrity affects GABAA receptor, but not NMDA receptor modulation by psychopharmacological compounds. Int J Neuropsychopharmacol 16:1361–1371
Rosenhouse-Dantsker A, Levitan I (2012) Insights into structural determinants of cholesterol sensitivity of Kir channels. In: Levitan I, Barrantes F (eds) Cholesterol regulation of ion channels and receptors. John Wiley, NJ, pp 47–67
Korinek M, Vyklicky V, Borovska J, Lichnerova K, Kaniakova M, Krausova B, Krusek J, Balik A, Smejkalova T, Horak M, Vyklicky L (2015) Cholesterol modulates open probability and desensitization of NMDA receptors. J Physiol 593:2279–2293
Banerjee P, Joo JB, Buse JT, Dawson G (1995) Differential solubilization of lipids along with membrane proteins by different classes of detergents. Chem Phys Lipids 77:65–78
Chattopadhyay A, Jafurulla M, Kalipatnapu S, Pucadyil TJ, Harikumar KG (2005) Role of cholesterol in ligand binding and G-protein coupling of serotonin1A receptors solubilized from bovine hippocampus. Biochem Biophys Res Commun 327:1036–1041
Gimpl G (2010) Cholesterol-protein interaction: methods and cholesterol reporter molecules. Subcell Biochem 51:1–45
Fantini J, Barrantes FJ (2013) How cholesterol interacts with membrane proteins: an exploration of cholesterol-binding sites including CRAC, CARC, and tilted domains. Front Physiol 4:31
Li H, Papadopoulos V (1998) Peripheral-type benzodiazepine receptor function in cholesterol transport. Identification of a putative cholesterol recognition/interaction amino acid sequence and consensus pattern. Endocrinology 139:4991–4997
Epand RM (2006) Cholesterol and the interaction of proteins with membrane domains. Prog Lipid Res 45:279–294
Jafurulla M, Tiwari S, Chattopadhyay A (2011) Identification of cholesterol recognition amino acid consensus (CRAC) motif in G-protein coupled receptors. Biochem Biophys Res Commun 404:569–573
Hanson MA, Cherezov V, Griffith MT, Roth CB, Jaakola V-P, Chien EYT, Velasquez J, Kuhn P, Stevens RC (2008) A specific cholesterol binding site is established by the 2.8 Å structure of the human β2-adrenergic receptor. Structure 16:897–905
Brown MS, Goldstein JL (1999) A proteolytic pathway that controls the cholesterol content of membranes, cells, and blood. Proc Natl Acad Sci U S A 96:11041–11048
Kuwabara PE, Labouesse M (2002) The sterol-sensing domain: multiple families, a unique role? Trends Genet 18:193–201
Baier CJ, Fantini J, Barrantes FJ (2011) Disclosure of cholesterol recognition motifs in transmembrane domains of the human nicotinic acetylcholine receptor. Sci Rep 1:69
Fantini J, Di Scala C, Evans LS, Williamson PTF, Barrantes FJ (2016) A mirror code for protein-cholesterol interactions in the two leaflets of biological membranes. Sci Rep 6:21907
Jamin N, Neumann J-M, Ostuni MA, Vu TKN, Yao Z-X, Murail S, Robert J-C, Giatzakis C, Papadopoulos V, Lacapère J-J (2005) Characterization of the cholesterol recognition amino acid consensus sequence of the peripheral-type benzodiazepine receptor. Mol Endocrinol 19:588–594
Epand RF, Thomas A, Brasseur R, Vishwanathan SA, Hunter E, Epand RM (2006) Juxtamembrane protein segments that contribute to recruitment of cholesterol into domains. Biochemistry 45:6105–6114
Härtel S, Diehl HA, Ojeda F (1998) Methyl-β-cyclodextrins and liposomes as water-soluble carriers for cholesterol incorporation into membranes and its evaluation by a microenzymatic fluorescence assay and membrane fluidity-sensitive dyes. Anal Biochem 258:277–284
Zidovetzki R, Levitan I (2007) Use of cyclodextrins to manipulate plasma membrane cholesterol content: evidence, misconceptions and control strategies. Biochim Biophys Acta 1768:1311–1324
Gimpl G, Gehrig-Burger K (2011) Probes for studying cholesterol binding and cell biology. Steroids 76:216–231
Chattopadhyay A, Jafurulla M (2012) Role of membrane cholesterol in leishmanial infection. Adv Exp Med Biol 749:201–213
López CA, de Vries AH, Marrink SJ (2013) Computational microscopy of cyclodextrin mediated cholesterol extraction from lipid model membranes. Sci Rep 3:2071
Breslow R, Zhang B (1996) Cholesterol recognition and binding by cyclodextrin dimers. J Am Chem Soc 118:8495–8496
Tsamaloukas A, Szadkowska H, Slotte JP, Heerklotz H (2005) Interactions of cholesterol with lipid membranes and cyclodextrin characterized by calorimetry. Biophys J 89:1109–1119
Elias PM, Goerke J, Friend DS, Brown BE (1978) Freeze-fracture identification of sterol-digitonin complexes in cell and liposome membranes. J Cell Biol 78:577–596
Nishikawa M, Nojima S, Akiyama T, Sankawa U, Inoue K (1984) Interaction of digitonin and its analogs with membrane cholesterol. J Biochem 96:1231–1239
Paila YD, Pucadyil TJ, Chattopadhyay A (2005) The cholesterol-complexing agent digitonin modulates ligand binding of the bovine hippocampal serotonin1A receptor. Mol Membr Biol 22:241–249
Holz RW (1974) The effects of the polyene antibiotics nystatin and amphotericin B on thin lipid membranes. Ann N Y Acad Sci 235:469–479
Bolard J (1986) How do the polyene macrolide antibiotics affect the cellular membrane properties? Biochim Biophys Acta 864:257–304
Coutinho A, Prieto M (2003) Cooperative partition model of nystatin interaction with phospholipid vesicles. Biophys J 84:3061–3078
Pucadyil TJ, Shrivastava S, Chattopadhyay A (2004) The sterol-binding antibiotic nystatin differentially modulates ligand binding of the bovine hippocampal serotonin1A receptor. Biochem Biophys Res Commun 320:557–562
Readio JD, Bittman R (1982) Equilibrium binding of amphotericin B and its methyl ester and borate complex to sterols. Biochim Biophys Acta 685:219–224
Mouri R, Konoki K, Matsumori N, Oishi T, Murata M (2008) Complex formation of amphotericin B in sterol-containing membranes as evidenced by surface plasmon resonance. Biochemistry 47:7807–7815
Paila YD, Saha B, Chattopadhyay A (2010) Amphotericin B inhibits entry of Leishmania donovani into primary macrophages. Biochem Biophys Res Commun 399:429–433
Chattopadhyay A, Jafurulla M (2011) A novel mechanism for an old drug: amphotericin B in the treatment of visceral leishmaniasis. Biochem Biophys Res Commun 416:7–12
Kamiński DM (2014) Recent progress in the study of the interactions of amphotericin B with cholesterol and ergosterol in lipid environments. Eur Biophys J 43:453–467
Istvan ES, Deisenhofer J (2001) Structural mechanism for statin inhibition of HMG-CoA reductase. Science 292:1160–1164
Shrivastava S, Pucadyil TJ, Paila YD, Ganguly S, Chattopadhyay A (2010) Chronic cholesterol depletion using statin impairs the function and dynamics of human serotonin1A receptors. Biochemistry 49:5426–5435
Singh P, Saxena R, Srinivas G, Pande G, Chattopadhyay A (2013) Cholesterol biosynthesis and homeostasis in regulation of the cell cycle. PLoS One 8:e58833
Kandutsch AA, Russell AE (1960) Preputial gland tumor sterols: III A metabolic pathway from lanosterol to cholesterol. J Biol Chem 235:2256–2261
Smith DW, Lemli L, Opitz JM (1964) A newly recognized syndrome of multiple congenital anomalies. J Pediatr 64:210–217
Waterham HR, Wanders RJA (2000) Biochemical and genetic aspects of 7-dehydrocholesterol reductase and Smith-Lemli-Opitz syndrome. Biochim Biophys Acta 1529:340–356
Paila YD, Murty MRVS, Vairamani M, Chattopadhyay A (2008) Signaling by the human serotonin1A receptor is impaired in cellular model of Smith-Lemli-Opitz Syndrome. Biochim Biophys Acta 1778:1508–1516
Porter FD, Herman GE (2011) Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 52:6–34
Kanungo S, Soares N, He M, Steiner RD (2013) Sterol metabolism disorders and neurodevelopment-an update. Dev Disabil Res Rev 17:197–210
Bloch KE (1983) Sterol structure and membrane function. CRC Crit Rev Biochem 14:47–92
Clayton P, Mills K, Keeling J, FitzPatrick D (1996) Desmosterolosis: a new inborn error of cholesterol biosynthesis. Lancet 348:404
FitzPatrick DR, Keeling JW, Evans MJ, Kan AE, Bell JE, Porteous MEM, Mills K, Winter RM, Clayton PT (1998) Clinical phenotype of desmosterolosis. Am J Med Genet 75:145–152
Waterham HR, Koster J, Romeijn GJ, Hennekam RCM, Vreken P, Andersson HC, FitzPatrick DR, Kelley RI, Wanders RJA (2001) Mutations in the 3β-hydroxysterol Δ24-reductase gene cause desmosterolosis, an autosomal recessive disorder of cholesterol biosynthesis. Am J Hum Genet 69:685–694
Singh P, Jafurulla M, Paila YD, Chattopadhyay A (2011) Desmosterol replaces cholesterol for ligand binding function of the serotonin1A receptor in solubilized hippocampal membranes: support for nonannular binding sites for cholesterol? Biochim Biophys Acta 1808:2428–2434
Roux C, Wolf C, Mulliez N, Gaoua W, Cormier V, Chevy F, Citadelle D (2000) Role of cholesterol in embryonic development. Am J Clin Nutr 71(5 Suppl):1270S–1279S
Sampson NS, Vrielink A (2003) Cholesterol oxidases: a study of nature’s approach to protein design. Acc Chem Res 36:713–722
Pucadyil TJ, Shrivastava S, Chattopadhyay A (2005) Membrane cholesterol oxidation inhibits ligand binding function of hippocampal serotonin1A receptors. Biochem Biophys Res Commun 331:422–427
Kalipatnapu S, Chattopadhyay A (2005) Membrane protein solubilization: recent advances and challenges in solubilization of serotonin1A receptors. IUBMB Life 57:505–512
Chattopadhyay A, Rao BD, Jafurulla M (2015) Solubilization of G protein-coupled receptors: a convenient strategy to explore lipid-receptor interaction. Methods Enzymol 557:117–134
Jones OT, Eubanks JH, Earnest JP, McNamee MG (1988) A minimum number of lipids are required to support the functional properties of the nicotinic acetylcholine receptor. Biochemistry 27:3733–3742
Kirilovsky J, Schramm M (1983) Delipidation of a β-adrenergic receptor preparation and reconstitution by specific lipids. J Biol Chem 258:6841–6849
Pucadyil TJ, Kalipatnapu S, Chattopadhyay A (2005) The serotonin1A receptor: a representative member of the serotonin receptor family. Cell Mol Neurobiol 25:553–580
Kalipatnapu S, Chattopadhyay A (2007) Membrane organization and function of the serotonin1A receptor. Cell Mol Neurobiol 27:1097–1116
Singh P, Paila YD, Chattopadhyay A (2007) Differential effects of cholesterol and 7-dehydrocholesterol on the ligand binding activity of the hippocampal serotonin1A receptors: implications in SLOS. Biochem Biophys Res Commun 358:495–499
Chattopadhyay A, Paila YD, Jafurulla M, Chaudhuri A, Singh P, Murty MRVS, Vairamani M (2007) Differential effects of cholesterol and 7- dehydrocholesterol on ligand binding of solubilized hippocampal serotonin1A receptors: implications in SLOS. Biochem Biophys Res Commun 363:800–805
Singh DK, Rosenhouse-Dantsker A, Nichols CG, Enkvetchakul D, Levitan I (2009) Direct regulation of prokaryotic Kir channel by cholesterol. J Biol Chem 284:30727–30736
Westover EJ, Covey DF (2004) The enantiomer of cholesterol. J Membr Biol 202:61–72
Covey DF (2009) ent-Steroids: novel tools for studies of signaling pathways. Steroids 74:577–585
Bandari S, Chakraborty H, Covey DF, Chattopadhyay A (2014) Membrane dipole potential is sensitive to cholesterol stereospecificity: implications for receptor function. Chem Phys Lipids 184:25–29
Xu F, Rychnovsky SD, Belani JD, Hobbs HH, Cohen JC, Rawson RB (2005) Dual roles for cholesterol in mammalian cells. Proc Natl Acad Sci U S A 102:14551–14556
Mickus DE, Levitt DG, Rychnovsky SD (1992) Enantiomeric cholesterol as a probe of ion-channel structure. J Am Chem Soc 114:359–360
D’Avanzo N, Hyrc K, Enkvetchakul D, Covey DF, Nichols CG (2011) Enantioselective protein-sterol interactions mediate regulation of both prokaryotic and eukaryotic inward rectifier K+ channels by cholesterol. PLoS One 6:e19393
Kristiana I, Luu W, Stevenson J, Cartland S, Jessup W, Belani JD, Rychnovsky SD, Brown AJ (2012) Cholesterol through the looking glass: ability of its enantiomer also to elicit homeostatic responses. J Biol Chem 287:33897–33904
Pierce KL, Premont RT, Lefkowitz RJ (2002) Seven-transmembrane receptors. Nat Rev Mol Cell Biol 3:639–650
Rosenbaum DM, Rasmussen SGF, Kobilka BK (2009) The structure and function of G-protein-coupled receptors. Nature 459:356–363
Granier S, Kobilka B (2012) A new era of GPCR structural and chemical biology. Nat Chem Biol 8:670–673
Heng BC, Aubel D, Fussenegger M (2013) An overview of the diverse roles of G-protein coupled receptors (GPCRs) in the pathophysiology of various human diseases. Biotechnol Adv 31:1676–1694
Jacobson KA (2015) New paradigms in GPCR drug discovery. Biochem Pharmacol 98:541–555
Tautermann CS (2014) GPCR structures in drug design, emerging opportunities with new structures. Bioorg Med Chem Lett 24:4073–4079
Jafurulla M, Rao BD, Sreedevi S, Ruysschaert J-M, Covey DF, Chattopadhyay A (2014) Stereospecific requirement of cholesterol in the function of the serotonin1A receptor. Biochim Biophys Acta 1838:158–163
Jentsch TJ, Hübner CA, Fuhrmann JC (2004) Ion channels: function unravelled by dysfunction. Nat Cell Biol 6:1039–1047
Romanenko VG, Rothblat GH, Levitan I (2002) Modulation of endothelial inward-rectifier K+ current by optical isomers of cholesterol. Biophys J 83:3211–3222
Addona GH, Sandermann H Jr, Kloczewiak MA, Miller KW (2003) Low chemical specificity of the nicotinic acetylcholine receptor sterol activation site. Biochim Biophys Acta 1609:177–182
Killian JA (1992) Gramicidin and gramicidin–lipid interactions. Biochim Biophys Acta 1113:391–425
Koeppe RE II, Andersen OS (1996) Engineering the gramicidin channel. Annu Rev Biophys Biomol Struct 25:231–258
Kelkar DA, Chattopadhyay A (2007) The gramicidin ion channel: a model membrane protein. Biochim Biophys Acta 1768:2011–2025
Brown MS, Goldstein JL (2009) Cholesterol feedback: from Schoenheimer’s bottle to Scap’s MELADL. J Lipid Res 50:S15–S27
Brown AJ, Sun L, Feramisco JD, Brown MS, Goldstein JL (2002) Cholesterol addition to ER membranes alters conformation of SCAP, the SREBP escort protein that regulates cholesterol metabolism. Mol Cell 10:237–245
Adams CM, Goldstein JL, Brown MS (2003) Cholesterol-induced conformational change in SCAP enhanced by Insig proteins and mimicked by cationic amphiphiles. Proc Natl Acad Sci U S A 100:10647–10652
Radhakrishnan A, Goldstein JL, McDonald JG, Brown MS (2008) Switch-like control of SREBP-2 transport triggered by small changes in ER cholesterol: a delicate balance. Cell Metab 8:512–521
Luker GD, Pica CM, Kumar AS, Covey DF, Piwnica-Worms D (2000) Effects of cholesterol and enantiomeric cholesterol on P-glycoprotein localization and function in low-density membrane domains. Biochemistry 39:7651–7661
Liu J, Chang CCY, Westover EJ, Covey DF, Chang T-Y (2005) Investigating the allosterism of acyl-CoA:cholesterol acyltransferase (ACAT) by using various sterols: in vitro and intact cell studies. Biochem J 391:389–397
Ikigai H, Akatsuka A, Tsujiyama H, Nakae T, Shimamura T (1996) Mechanism of membrane damage by El Tor hemolysin of Vibrio cholerae O1. Infect Immun 64:2968–2973
Bhakdi S, Tranum-Jensen J, Sziegoleit A (1985) Mechanism of membrane damage by streptolysin-O. Infect Immun 47:52–60
Zitzer A, Westover EJ, Covey DF, Palmer M (2003) Differential interaction of the two cholesterol-dependent, membrane-damaging toxins, streptolysin O and Vibrio cholerae cytolysin, with enantiomeric cholesterol. FEBS Lett 553:229–231
Palmer M (2004) Cholesterol and the activity of bacterial toxins. FEMS Microbiol Lett 238:281–289
Acknowledgments
Work in A.C.’s laboratory was supported by the Council of Scientific and Industrial Research (Govt. of India) Network project BSC0115. A.C. is an Adjunct Professor of Tata Institute of Fundamental Research (Mumbai), RMIT University (Melbourne, Australia), Indian Institute of Technology (Kanpur), and Indian Institute of Science Education and Research (Mohali). A.C. gratefully acknowledges J.C. Bose Fellowship (Dept. of Science and Technology, Govt. of India). Some of the work described in this article was carried out by former members of A.C.’s research group whose contributions are gratefully acknowledged. We thank G. Aditya Kumar for help in making figures, and members of the Chattopadhyay laboratory for critically reading the manuscript.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Jafurulla, M., Chattopadhyay, A. (2017). Structural Stringency of Cholesterol for Membrane Protein Function Utilizing Stereoisomers as Novel Tools: A Review. In: Gelissen, I., Brown, A. (eds) Cholesterol Homeostasis. Methods in Molecular Biology, vol 1583. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-6875-6_3
Download citation
DOI: https://doi.org/10.1007/978-1-4939-6875-6_3
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-6873-2
Online ISBN: 978-1-4939-6875-6
eBook Packages: Springer Protocols